Persistence of anti-desmoglein 3 IgG(+) B-cell clones in pemphigus patients over years.
about
Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune diseaseADAMTS13 autoantibodies cloned from patients with acquired thrombotic thrombocytopenic purpura: 1. Structural and functional characterization in vitroShifting Focus in the Therapeutics of Immunobullous Disease.Robust memory responses against influenza vaccination in pemphigus patients previously treated with rituximabRituximab therapy improves recalcitrant Pemphigus vulgaris.Proteomic Analysis of Pemphigus Autoantibodies Indicates a Larger, More Diverse, and More Dynamic Repertoire than Determined by B Cell Genetics.Rituximab therapy in pemphigus and other autoantibody-mediated diseases.Setting the target for pemphigus vulgaris therapy.Immune response in pemphigus and beyond: progresses and emerging concepts.Mechanisms of Disease: Pemphigus and Bullous Pemphigoid.Determinants of VH1-46 Cross-Reactivity to Pemphigus Vulgaris Autoantigen Desmoglein 3 and Rotavirus Antigen VP6.Pemphigus: a Comprehensive Review on Pathogenesis, Clinical Presentation and Novel Therapeutic Approaches.Crescendo response to rituximab in oral pemphigus vulgaris: a case with 7-year follow-up.B Cell Modulation Strategies in Autoimmune Diseases: New Concepts.Humoral Epitope Spreading in Autoimmune Bullous Diseases.Pemphigus
P2860
Q28276800-7836F6CF-4C66-4CBE-8B69-B91A4F046574Q33431193-42438A87-DF1C-43A0-B0B5-1A7C5071261DQ33737974-C4517D18-CF9C-4063-8995-3F0F13F0B278Q33798060-2EF1B6AA-D103-4F00-A08A-993B01144DD7Q36008711-65136C7C-96CD-4C2C-AFCC-41881CFE302AQ37573339-D60A551E-063A-472F-B312-042E5222363CQ37620483-01129602-526D-4E0C-A9B4-1959F5F459FCQ37677416-330D3100-4529-4858-BEC5-9244ABF559AAQ38644346-4F4F0222-6C00-4C53-B8A3-BF64832AB595Q38747187-EEF36D53-4801-4C6E-AC3E-97175F3B8872Q40617500-478D6B21-3A6C-4DA1-A2C4-AF826F8C4EA3Q47219879-AF763CF4-011F-4D62-8967-3AD6725FBA8CQ53126755-9BCEA89D-E3F5-4F9B-B003-0DCB538FD916Q54980047-969A0D44-1174-420F-8256-943C9D790B27Q55262188-B68F9EFF-7D07-459C-857B-073712DE67EEQ56603745-6809E2AA-9606-42DF-8ED3-C1C055DE2498
P2860
Persistence of anti-desmoglein 3 IgG(+) B-cell clones in pemphigus patients over years.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Persistence of anti-desmoglein 3 IgG
@nl
Persistence of anti-desmoglein 3 IgG(+) B-cell clones in pemphigus patients over years.
@ast
Persistence of anti-desmoglein 3 IgG(+) B-cell clones in pemphigus patients over years.
@en
type
label
Persistence of anti-desmoglein 3 IgG
@nl
Persistence of anti-desmoglein 3 IgG(+) B-cell clones in pemphigus patients over years.
@ast
Persistence of anti-desmoglein 3 IgG(+) B-cell clones in pemphigus patients over years.
@en
prefLabel
Persistence of anti-desmoglein 3 IgG
@nl
Persistence of anti-desmoglein 3 IgG(+) B-cell clones in pemphigus patients over years.
@ast
Persistence of anti-desmoglein 3 IgG(+) B-cell clones in pemphigus patients over years.
@en
P2093
P2860
P356
P1476
Persistence of anti-desmoglein 3 IgG(+) B-cell clones in pemphigus patients over years.
@en
P2093
Aimee S Payne
Chenyan Lin
Don L Siegel
John R Stanley
Stephen Kacir
P2860
P2888
P304
P356
10.1038/JID.2014.291
P407
P577
2014-07-14T00:00:00Z
P5875
P6179
1007445847